NOS3 and neoplasm: Additionally, kallistatin may antagonize endothelial nitric oxide synthase (eNOS), sirtuin 1 (SIRT1) and microRNA (miRNAs)-mediated inflammation, oxidative stress and tumor growth via its active site (12).